Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Leptin and Ghrelin in Excessive Gestational Weight Gain-Association between Mothers and Offspring.

Patro-Małysza J, Trojnar M, Skórzyńska-Dziduszko KE, Kimber-Trojnar Ż, Darmochwał-Kolarz D, Czuba M, Leszczyńska-Gorzelak B.

Int J Mol Sci. 2019 May 15;20(10). pii: E2398. doi: 10.3390/ijms20102398.

2.

Vaspin in Serum and Urine of Post-Partum Women with Excessive Gestational Weight Gain.

Trojnar M, Patro-Małysza J, Kimber-Trojnar Ż, Czuba M, Mosiewicz J, Leszczyńska-Gorzelak B.

Medicina (Kaunas). 2019 Mar 23;55(3). pii: E76. doi: 10.3390/medicina55030076.

3.

Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus.

Trojnar M, Patro-Małysza J, Kimber-Trojnar Ż, Leszczyńska-Gorzelak B, Mosiewicz J.

Cells. 2019 Mar 8;8(3). pii: E227. doi: 10.3390/cells8030227. Review.

4.

FABP4 in Gestational Diabetes-Association between Mothers and Offspring.

Patro-Małysza J, Trojnar M, Kimber-Trojnar Ż, Mierzyński R, Bartosiewicz J, Oleszczuk J, Leszczyńska-Gorzelak B.

J Clin Med. 2019 Feb 27;8(3). pii: E285. doi: 10.3390/jcm8030285.

5.

Umbilical Cord SFRP5 Levels of Term Newborns in Relation to Normal and Excessive Gestational Weight Gain.

Kimber-Trojnar Ż, Patro-Małysza J, Trojnar M, Darmochwał-Kolarz D, Oleszczuk J, Leszczyńska-Gorzelak B.

Int J Mol Sci. 2019 Jan 30;20(3). pii: E595. doi: 10.3390/ijms20030595.

6.

Nesfatin-1 and Vaspin as Potential Novel Biomarkers for the Prediction and Early Diagnosis of Gestational Diabetes Mellitus.

Mierzyński R, Poniedziałek-Czajkowska E, Dłuski D, Patro-Małysza J, Kimber-Trojnar Ż, Majsterek M, Leszczyńska-Gorzelak B.

Int J Mol Sci. 2019 Jan 4;20(1). pii: E159. doi: 10.3390/ijms20010159.

7.

Fatty Acid-Binding Protein 4-An "Inauspicious" Adipokine-In Serum and Urine of Post-Partum Women with Excessive Gestational Weight Gain and Gestational Diabetes Mellitus.

Kimber-Trojnar Ż, Patro-Małysza J, Trojnar M, Skórzyńska-Dziduszko KE, Bartosiewicz J, Oleszczuk J, Leszczyńska-Gorzelak B.

J Clin Med. 2018 Dec 2;7(12). pii: E505. doi: 10.3390/jcm7120505.

8.

Heat Shock Proteins as a Potential Therapeutic Target in the Treatment of Gestational Diabetes Mellitus: What We Know so Far.

Skórzyńska-Dziduszko KE, Kimber-Trojnar Ż, Patro-Małysza J, Stenzel-Bembenek A, Oleszczuk J, Leszczyńska-Gorzelak B.

Int J Mol Sci. 2018 Oct 17;19(10). pii: E3205. doi: 10.3390/ijms19103205. Review.

9.

Ghrelin in Serum and Urine of Post-Partum Women with Gestational Diabetes Mellitus.

Kimber-Trojnar Ż, Patro-Małysza J, Skórzyńska-Dziduszko KE, Oleszczuk J, Trojnar M, Mierzyński R, Leszczyńska-Gorzelak B.

Int J Mol Sci. 2018 Oct 1;19(10). pii: E3001. doi: 10.3390/ijms19103001.

10.

Predictors of cesarean delivery in cervical ripening and labor induction with Foley catheter.

Marciniak B, Patro-Małysza J, Kimber-Trojnar Ż, Oleszczuk J, Leszczyńska-Gorzelak B.

J Matern Fetal Neonatal Med. 2018 Jul 18:1-6. doi: 10.1080/14767058.2018.1486816. [Epub ahead of print]

PMID:
29879855
11.

Fetal programming of the metabolic syndrome.

Marciniak A, Patro-Małysza J, Kimber-Trojnar Ż, Marciniak B, Oleszczuk J, Leszczyńska-Gorzelak B.

Taiwan J Obstet Gynecol. 2017 Apr;56(2):133-138. doi: 10.1016/j.tjog.2017.01.001. Review.

12.

Editorial: Metabolic Syndrome in Pregnancy.

Kimber-Trojnar Ż.

Curr Pharm Biotechnol. 2016;17(7):572. No abstract available.

PMID:
27165110
13.

A Prevention of Pre-eclampsia with the Use of Acetylsalicylic Acid and Low-molecular Weight Heparin - Molecular Mechanisms.

Darmochwal-Kolarz D, Kolarz B, Korzeniewski M, Kimber-Trojnar Z, Patro-Malysza J, Mierzynski R, Przegalinska-Kałamucka M, Oleszczuk J.

Curr Pharm Biotechnol. 2016;17(7):624-8. Review.

PMID:
26927215
14.

Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders.

Mierzynski R, Dluski D, Darmochwal-Kolarz D, Poniedziałek-Czajkowska E, Leszczynska-Gorzelak B, Kimber-Trojnar Z, Agnieszka-Wankowicz, Oleszczuk J.

Curr Pharm Biotechnol. 2016;17(7):587-96. Review.

PMID:
26927210
15.

An Interplay between Obesity and Inflammation in Gestational Diabetes Mellitus.

Skórzyńska-Dziduszko KE, Kimber-Trojnar Ż, Patro-Małysza J, Olszewska A, Zaborowski T, Małecka-Massalska T.

Curr Pharm Biotechnol. 2016;17(7):603-13. Review.

PMID:
26813307
16.

The impact of substance P on the pathogenesis of insulin resistance leading to gestational diabetes.

Patro-Malysza J, Kimber-Trojnar Z, Skorzynska-Dziduszko K, Marciniak B, Darmochwal-Kolarz D, Bartosiewicz J, Leszczynska-Gorzelak B, Oleszczuk J.

Curr Pharm Biotechnol. 2014;15(1):32-7. Review.

PMID:
24720596
17.

Anticoagulant therapy in pregnant patients with metabolic syndrome: a review.

Mierzynski R, Poniedzialek-Czajkowska E, Kimber-Trojnar Z, Leszczynska-Gorzelak B, Oleszczuk J.

Curr Pharm Biotechnol. 2014;15(1):47-63. Review.

PMID:
24720594
18.

Polyunsaturated fatty acids in pregnancy and metabolic syndrome: a review.

Poniedzialek-Czajkowska E, Mierzynski R, Kimber-Trojnar Z, Leszczynska-Gorzelak B, Oleszczuk J.

Curr Pharm Biotechnol. 2014;15(1):84-99. Review.

PMID:
24720591
19.

Is glyburide safe in pregnancy?

Kimber-Trojnar Ż, Marciniak B, Patro-Malysza J, Skorzynska-Dziduszko K, Poniedzialek-Czajkowska E, Mierzynski R, Galczynski K, Trojnar M, Leszczynska-Gorzelak B, Oleszczuk J.

Curr Pharm Biotechnol. 2014;15(1):100-12. Review.

PMID:
24720590
20.

Editorial: "pregnancy in women with metabolic syndrome".

Kimber-Trojnar Z.

Curr Pharm Biotechnol. 2014;15(1):1-2. No abstract available.

PMID:
24720589

Supplemental Content

Loading ...
Support Center